Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
sanofi
1 vial
Cemiplimab-rwlc
Keep in cold place
Delivering To:
Overview
Cemiplimab-rwlc 350mg Injection is used to treat a type of skin cancer that has spread to other areas of the body that cannot be treated with radiation or surgery. It is given as an infusion into the vein. Do not self-administer this medicine.
Skin Cancer
Cemiplimab inhibits tumor growth by an immune-mediated mechanism, specifically by the inhibition of the programmed death receptor 1 (PD-1) treating cutaneous squamous cell carcinoma. 350mg IV over 30 minutes every 3 weeks until disease progression.
Cemiplimab-rwlc 350mg Injection may cause some serious and unwanted side effects. It requires immediate medical attention otherwise it can also lead to higher risk. Discuss the risks and benefits of this medication with a medical advisor before starting the treatment.
Diarrhea
Fever
Cough
Itching
Abdominal pain
Dizziness
Sore throat
Headache
Nausea
Vomiting
Skin rash
Blurred vision
Difficulty in urination
Take Cemiplimab-rwlc 350mg Injection as prescribed by your doctor. Do not self-administer. The injection is given as an infusion into your vein by a doctor or nurse.
In case of an overdose, the doctor will provide emergency medical treatment.
Alcohol
unsafe
It is advisable not to consume alcohol while taking this medicine.
Pregnancy
consult your doctor
Do not take Cemiplimab-rwlc 350mg Injection without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
caution
Do not takev without a doctor's consultation in case of kidney problems.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine.
It is advisable not to miss a dose. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately.
Cemiplimab-rwlc injection is used to treat a certain type of skin cancer that has spread to other parts of the body or cannot be treated with radiation or surgery.
This medication works by changing the action of the immune system and directing it to kill or stop the growth of cancer cells. This medicine belongs to a class of drugs known as monoclonal antibodies.
This medicine is given as an infusion into the vein. It is given once every 3 weeks. The infusion usually takes 30 minutes to complete.
This medicine may decrease your ability to drive or affect your vision. Do not drive if any symptoms occur.
Store this medicine at room temperature. Do not shake or freeze the medicine.
sanofi
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.